Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Metadata
Title
Radiation Dose, Chemotherapy and Risk of Lung Cancer After Breast Cancer Treatment
Authors
Carole Rubino
Florent de Vathaire
Ibrahima Diallo
Akthar Shamsaldin
Emmanuel Grimaud
Martine Labbe
Genevieve Contesso
Monique Le
Publication date
01-09-2002
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1016590315382

Other articles of this Issue 1/2002

Breast Cancer Research and Treatment 1/2002 Go to the issue

OriginalPaper

Dietary Intake of Selected Fatty Acids, Cholesterol and Carotenoids and Estrogen Receptor Status in Premenopausal Breast Cancer Patients

OriginalPaper

Physiotherapy After Breast Cancer Surgery: Results of a Randomised Controlled Study to Minimise Lymphoedema

OriginalPaper

Amplified Centrosomes in Breast Cancer: A Potential Indicator of Tumor Aggressiveness

Instructions for Authors

Instructions for Authors

OriginalPaper

Doxycycline-Inducible Expression of SPARC/ Osteonectin/ BM40 in MDA-MB-231 Human Breast Cancer Cells Results in Growth Inhibition

OriginalPaper

Ki-67 Immunostaining Activity is Higher in Positive Axillary Lymph Nodes than in the Primary Breast Tumor
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits